Jounce Therapeutics(JNCE)

1.88 0.00 0.0%

今开:0.0昨收:1.88
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:9.895468E7

Jounce Therapeutics的热门讨论

美股滚雪球2023-02-24 09:56

$Jounce Therapeutics(JNCE)$ 宣布与总部位于英国的Redx Pharma进行全股票合并,合并后的公司将被称为Redx,并以Redx的股票代码在NASDAQ上市。
根据合并方案,预计Redx股东将持有该集团约63%的股份,而Jounce股东将持有剩余约37%的股份。
就业务合并而言,预计将向原始Jounce股东分配一项...查看全文

其他

Jounce Therapeutics(JNCE)2023-05-04 19:33

$Jounce Therapeutics(JNCE)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001640455-23-000100  Act: 33  Size: 46 KB 网页链接查看全文

其他

Jounce Therapeutics(JNCE)2023-05-04 19:36

$Jounce Therapeutics(JNCE)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001640455-23-000105  Act: 33  Size: 46 KB 网页链接查看全文

持股变动声明

Jounce Therapeutics(JNCE)2023-05-04 19:48

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000107  Size: 24 KB 网页链接查看全文

持股变动声明

Jounce Therapeutics(JNCE)2023-05-04 19:51

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000114  Size: 10 KB 网页链接查看全文

持股变动声明

Jounce Therapeutics(JNCE)2023-05-04 19:51

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000111  Size: 20 KB 网页链接查看全文

其他

Jounce Therapeutics(JNCE)2023-05-04 19:12

$Jounce Therapeutics(JNCE)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001640455-23-000084  Act: 34  Size: 34 KB 网页链接查看全文

超过5%股东持股披露「修订」

Jounce Therapeutics(JNCE)2023-05-06 04:36

$Jounce Therapeutics(JNCE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001214659-23-006565  Act: 34  Size: 95 KB 网页链接查看全文

持股变动声明

Jounce Therapeutics(JNCE)2023-05-06 04:42

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027688  Size: 12 KB 网页链接查看全文

持股变动声明

Jounce Therapeutics(JNCE)2023-05-04 19:48

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000106  Size: 16 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42

Jounce Therapeutics的新闻

Jounce(JNCE.US)盘前暴涨30% 将与Redx达成4.25亿美元合并交易

智通财经APP获悉,英国生物技术公司Redx Pharma plc和美国Jounce Therapeutics Inc(JNCE.US)将合并,成立一家4.25亿美元的实体,专门治疗癌症和纤维化疾病。截至发稿,Jounce盘前涨30.25%,报1.29美元。 两家公司周四表示,Redx股东将以... 网页链接

Jounce Therapeutics的公告

首次持股声明

$Jounce Therapeutics(JNCE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-23-027685  Size: 7 KB 网页链接

持股变动声明

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027688  Size: 12 KB 网页链接

持股变动声明

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027692  Size: 6 KB 网页链接

超过5%股东持股披露「修订」

$Jounce Therapeutics(JNCE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001214659-23-006565  Act: 34  Size: 95 KB 网页链接

生效批准

$Jounce Therapeutics(JNCE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001276  Act: 33  Size: 1 KB 网页链接

生效批准

$Jounce Therapeutics(JNCE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001275  Act: 33  Size: 1 KB 网页链接

其他

$Jounce Therapeutics(JNCE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000336  Act: 34  Size: 2 KB 网页链接

持股变动声明

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000111  Size: 20 KB 网页链接

持股变动声明

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000112  Size: 26 KB 网页链接

持股变动声明

$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000113  Size: 8 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41